For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Specialized Community Disease Management | Specialized Community Disease Management: Specialized Community Disease Management is 90-day program that employs specialized teams including a trained clinical social worker and a peer-specialist community health worker who provide evidence-based telephone continuing care, home visits, and focus on patients' substance use following hospital discharge. | 1 | None | 23 | 49 | 0 | 49 | View |
| Treatment As Usual | Treatment As Usual: Treatment as Usual is a 90-day, post-discharge program that consists of medical monitoring by nurses and community health workers who have no special training in working with substance use disorder patients, and does not address substance use. | 3 | None | 14 | 48 | 0 | 48 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Hospitalization for cardiac arrest | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Hospitalization for Syncope | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Hospitalization for drug/alcohol use | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Inpatient Drug/Alcohol | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Death, Cause Unknown | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Hospitalization for congestive heart failure | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Hospitalization for COPD | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Hospitalization for Diabetes | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Hospitalization for end-stage renal disease | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Hospitalization for pneumonia | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Suicidal ideation/attempt | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Death related to congestive heart failure | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |